phospho-PLC-gamma 1 (Y783) Antibody (1016D)

R&D Systems | Catalog # MAB74542

Recombinant Monoclonal Antibody.
R&D Systems

Key Product Details

Validated by

Biological Validation

Species Reactivity

Validated:

Human, Mouse, Rat

Cited:

Human

Applications

Validated:

Immunocytochemistry

Cited:

Immunohistochemistry

Label

Unconjugated

Antibody Source

Recombinant Monoclonal Rabbit IgG Clone # 1016D
Loading...

Product Specifications

Immunogen

Phosphopeptide containing the human/mouse/rat PLC-gamma 1 Y783 site.
Accession # P19174

Specificity

Detects human, mouse, and rat PLC-gamma 1 when phosphorylated at Y783.

Clonality

Monoclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for phospho-PLC-gamma 1 (Y783) Antibody (1016D)

Phospho-PLC-?1 (Y783) antibody in A431 Human Cell Line by Immunocytochemistry (ICC).

Phospho-PLC‑ gamma 1 (Y783) in A431 Human Cell Line.

PLC- gamma1 phosphorylated at Y783 was detected in immersion fixed A431 human epithelial carcinoma cell line treated with Recombinant Human EGF (Catalog # 236-EG) using Rabbit Anti-Human Phospho-PLC- gamma1 (Y783) Polyclonal Antibody (Catalog # MAB74542) at 3 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Rabbit IgG Secondary Antibody (red; Catalog # NL004) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm and plasma membranes. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.
Detection of Mouse PLC-gamma 1 by Western Blot

Detection of Mouse PLC-gamma 1 by Western Blot

Cathelicidin-dependent signaling in platelets. a–i LL-37 induced signaling in isolated human platelets. a–c Flow cytometry analysis of platelet P-selectin surface expression in the presence of a the calcium chelator BAPTA (n = 5) or a phospholipase C inhibitor (U-73122, n = 6), b pertussis or cholera toxin to inhibit G-protein signaling (n = 4), or c inhibitors of tyrosine kinases Src-family kinases (Dasatinib, n = 7) and Syk (R406, n = 5). d Representative western blots of phosphorylated Src-family kinase and phosphorylated Syk upon incubation of platelets with LL-37. Collagen was used as positive control for tyrosine kinase phosphorylation, beta -actin served as loading control. Images are representative of three independent blots. e–i Flow cytometry analysis of LL-37 platelet P-selectin surface expression in the presence of e STAT3 small molecule inhibitor (Stattic, n = 6), f GPVI antibody (HGP5C4, n = 9), g GPIIb/IIIa antibody (Abciximab or Tirofiban, n = 4), h formyl-peptid-receptor (FPR1 or FPR2) antibody, and i inhibitors against the purinergic P2X7-receptor (Boc-MLF 10, WRW4 or A438079, n = 4). j–l CRAMP-induced signaling in isolated mouse platelets. j P-selectin surface expression in the presence of a GPVI depleting antibody (JAQ1, n = 6). k P-selectin surface expression and l phospholipase C phosphorylation in platelet lysates from platelet-specific Syk-deficient mice and respective littermates after stimulation with CRAMP (flow cytometry: n = 10 Syk−/− and n = 5 Syk+/+ animals, western blot analysis n = 5 each). Graphs show mean and SEM. P-values were determined by unpaired (a, f, j–l) or paired (c, e, h) t-test Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/29670076), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of PLC-gamma 1 by Western Blot

Detection of PLC-gamma 1 by Western Blot

Cathelicidin-dependent signaling in platelets. a–i LL-37 induced signaling in isolated human platelets. a–c Flow cytometry analysis of platelet P-selectin surface expression in the presence of a the calcium chelator BAPTA (n = 5) or a phospholipase C inhibitor (U-73122, n = 6), b pertussis or cholera toxin to inhibit G-protein signaling (n = 4), or c inhibitors of tyrosine kinases Src-family kinases (Dasatinib, n = 7) and Syk (R406, n = 5). d Representative western blots of phosphorylated Src-family kinase and phosphorylated Syk upon incubation of platelets with LL-37. Collagen was used as positive control for tyrosine kinase phosphorylation, beta -actin served as loading control. Images are representative of three independent blots. e–i Flow cytometry analysis of LL-37 platelet P-selectin surface expression in the presence of e STAT3 small molecule inhibitor (Stattic, n = 6), f GPVI antibody (HGP5C4, n = 9), g GPIIb/IIIa antibody (Abciximab or Tirofiban, n = 4), h formyl-peptid-receptor (FPR1 or FPR2) antibody, and i inhibitors against the purinergic P2X7-receptor (Boc-MLF 10, WRW4 or A438079, n = 4). j–l CRAMP-induced signaling in isolated mouse platelets. j P-selectin surface expression in the presence of a GPVI depleting antibody (JAQ1, n = 6). k P-selectin surface expression and l phospholipase C phosphorylation in platelet lysates from platelet-specific Syk-deficient mice and respective littermates after stimulation with CRAMP (flow cytometry: n = 10 Syk−/− and n = 5 Syk+/+ animals, western blot analysis n = 5 each). Graphs show mean and SEM. P-values were determined by unpaired (a, f, j–l) or paired (c, e, h) t-test. Image collected and cropped by CiteAb from the following open publication (https://www.nature.com/articles/s41467-018-03925-2), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of PLC-gamma 1 by Immunohistochemistry

Detection of PLC-gamma 1 by Immunohistochemistry

The JAK2-STAT pathway serves as the major downstream signaling pathway of the mutated PDGFB. mIF demonstrate the important downstream signaling pathway markers of PDGFR beta (p-JAK, p-Src, p-Erk1/2 and p-PLC gamma ) in FIA sections and NCA sections (A). Scale bar, 100 μm. Statistical analysis is performed to compare the mean fluorescence intensity of different signal markers between NCAs (n = 4) and FIAs (n = 5) (C). The expression of p-STAT1 and p-STAT3, which are downstream of p-JAK2, is detected by mIF in FIAs and NCAs. Scale bar, 50 μm (B). Statistical analysis of mean fluorescence intensity of these marks between NCAs (n = 4) and FIAs (n = 5) (D). Western blotting displays the expression of the important downstream signal pathway markers of PDGFR beta (p-JAK2, p-Src, p-Erk1/2 and p-PLC gamma ) in the HBVSMCs underwent different treatment in vitro (E). Relative density (normalized to Control) of immunoblot bands from (E) corresponding to pPLC gamma, p-JAK2, p-Src, and p-ERK1/2 (n = 3) (F). 'n' represented the number of samples. Three random fields were selected for statistical analysis in each sample, and the average value represented the detection value of this marker in this sample. Tukey's multiple comparisons test is conducted to evaluate the statistical differences. ns, no significant; ***padj < 0.001, ****padj < 0.0001. Image collected and cropped by CiteAb from the following open publication (https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-024-01040-7), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of PLC-gamma 1 by Western Blot

Detection of PLC-gamma 1 by Western Blot

The JAK2-STAT pathway serves as the major downstream signaling pathway of the mutated PDGFB. mIF demonstrate the important downstream signaling pathway markers of PDGFR beta (p-JAK, p-Src, p-Erk1/2 and p-PLC gamma ) in FIA sections and NCA sections (A). Scale bar, 100 μm. Statistical analysis is performed to compare the mean fluorescence intensity of different signal markers between NCAs (n = 4) and FIAs (n = 5) (C). The expression of p-STAT1 and p-STAT3, which are downstream of p-JAK2, is detected by mIF in FIAs and NCAs. Scale bar, 50 μm (B). Statistical analysis of mean fluorescence intensity of these marks between NCAs (n = 4) and FIAs (n = 5) (D). Western blotting displays the expression of the important downstream signal pathway markers of PDGFR beta (p-JAK2, p-Src, p-Erk1/2 and p-PLC gamma ) in the HBVSMCs underwent different treatment in vitro (E). Relative density (normalized to Control) of immunoblot bands from (E) corresponding to pPLC gamma, p-JAK2, p-Src, and p-ERK1/2 (n = 3) (F). 'n' represented the number of samples. Three random fields were selected for statistical analysis in each sample, and the average value represented the detection value of this marker in this sample. Tukey's multiple comparisons test is conducted to evaluate the statistical differences. ns, no significant; ***padj < 0.001, ****padj < 0.0001. Image collected and cropped by CiteAb from the following open publication (https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-024-01040-7), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for phospho-PLC-gamma 1 (Y783) Antibody (1016D)

Application
Recommended Usage

Immunocytochemistry

3-25 µg/mL
Sample: Immersion fixed A431 human epithelial carcinoma cell line treated with Recombinant Human EGF (Catalog # 236-EG)

Formulation, Preparation, and Storage

Purification

Protein A or G purified from cell culture supernatant

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS For liquid material, refer to CoA for concentration.


Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: PLC-gamma 1

Phospholipase C gamma-1 (PLC-gamma 1) is activated by receptor tyrosine kinases in response to growth factors and hormones, and phosphorylation at Tyr783 is a widely used indicator of activation. Activated PLC-gamma 1 catalyzes the hydrolysis of phosphatidylinositol 4,5-biphosphate to produce the second messengers inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 mobilizes the release of calcium while DAG activates protein kinase C. PLC-gamma 1 plays an important role in regulating cell proliferation and differentiation.

Long Name

Phospholipase C gamma 1

Alternate Names

PLCG1, PLCgamma 1, PPLCA

Entrez Gene IDs

5335 (Human); 18803 (Mouse); 25738 (Rat)

Gene Symbol

PLCG1

UniProt

Additional PLC-gamma 1 Products

Product Documents for phospho-PLC-gamma 1 (Y783) Antibody (1016D)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.


Can't find your language? Request a SDS in your language here.

Product Specific Notices for phospho-PLC-gamma 1 (Y783) Antibody (1016D)

For research use only

Citations for phospho-PLC-gamma 1 (Y783) Antibody (1016D)

Customer Reviews for phospho-PLC-gamma 1 (Y783) Antibody (1016D)

There are currently no reviews for this product. Be the first to review phospho-PLC-gamma 1 (Y783) Antibody (1016D) and earn rewards!

Have you used phospho-PLC-gamma 1 (Y783) Antibody (1016D)?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 for a review with an image

$10/€7/£6/$10CAN/¥1110 for a review without an image

Submit a review
Amazon Gift Card

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies